gene_name string | gene_id string | category string | cell_name string | tissue_type string | phenotype string | aging_type string | experiment string | description string | target_gene string | regulatory_type_of_target_gene string | target_gene_experiment string | target_gene_description string | regulatory_pathway string | regulatory_type_of_pathway string | pathway_experiment string | pathway_description string | species string | experimental_category string | aging_characteristic string | pmid int64 | source string | Alizarin_red_S_staining int64 | Annexin_V_binding_assay int64 | Apoptosis_assay int64 | Atomic_force_microscopy_imaging int64 | Autofluorescence int64 | Behavioral_assessment int64 | BrdU_analysis int64 | BrdU_assay int64 | CCK_8_assay int64 | CHIP int64 | Cell_activity_assay int64 | Cell_apoptosis_assay int64 | Cell_counting int64 | Cell_cycle_analysis int64 | Cell_growth_assay int64 | Cell_migration_assay int64 | Cell_morphological_analysis int64 | Cell_proliferation_assay int64 | Cell_transfection int64 | Cell_viability_assay int64 | ChIP_qPCR int64 | Clonal_expansion_assay int64 | Clonogenic_assay int64 | Colony_formation_assay int64 | Colony_formation?assay int64 | Comet_assay int64 | Crystal_violet_assay int64 | Cytokine_assay int64 | DAPI_staining int64 | DNA_FISH int64 | DNA_fiber_assay int64 | ELISA int64 | EdU_Assay int64 | EdU_assay int64 | EdU_assay/SA__gal_activity_assay int64 | EdU_cell_proliferation_assay int64 | FACS_analysis int64 | FCM_analysis int64 | FISH int64 | FITC_Annexin_V/PI int64 | Flow_cyotmetry int64 | Flow_cytometry int64 | Fluorescence_quenching_assay int64 | GO_analysis int64 | GSEA_analysis int64 | Giemsa_staining int64 | Growth_curve_assay int64 | Growth_kinetics_analysis int64 | Histochemical_staining int64 | Histological_images_analysis int64 | Histological_staining int64 | Hoechst_staining int64 | IHC int64 | IHC_staining int64 | Immunoblotting int64 | Immunochemical_staining int64 | Immunocytochemistry int64 | Immunofluorescence int64 | Immunohistochemical_staining int64 | Immunohistochemistry int64 | Immunostaining int64 | Immunostainings int64 | JC_1_probe_staining int64 | Ki67_staining int64 | Knockdown int64 | LDH_activity_assay int64 | Lifespan_assay int64 | Luciferase_reporter_assay int64 | MTS_assay int64 | MTT_assay int64 | Microarray int64 | Northern_blot int64 | PCR int64 | PI_staining int64 | Prevent int64 | RNA_seq int64 | ROS_assay int64 | ROS_staining int64 | RT__PCR int64 | RT_PCR int64 | RT_qPCR int64 | SA__Gal_activity_assay int64 | SA__gal_activity int64 | SA__gal_activity_assay int64 | SA__gal_staining int64 | SAHF int64 | Safranin_O_fast_green_staining int64 | Safranin_O/Fast_Green_staining int64 | Safranin_O int64 | Southern_Blot int64 | Southern_blot int64 | Southern_blot_analysis int64 | Southern_hybridization int64 | Southern_hybridization_analysis int64 | Survival_curve int64 | TRAP_assay int64 | TRF_analysis int64 | TRF_assay int64 | TUNEL_assay int64 | Telomerase_Assay int64 | Telomerase_activity_assay int64 | Telomerase_assay int64 | Telomere_length_assay int64 | Transmission_electron_microscopy int64 | Transwell_assay int64 | Trypan_blue_staining int64 | Tube_formation_assay int64 | WST_1_assay int64 | WST_8_assay int64 | Western_blot int64 | XTT_assay int64 | miRNA_qRT_PCR int64 | qPCR int64 | qPT_PCR int64 | qRT_PCR int64 | qRT¨CPCR int64 | ¦ÃH2AX_staining int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MIR675 | 100033819 | ncRNA | H9C2 | -- | Vascular disease | Prevent | EdU assay//SA--gal activity assay | The data showed that miR-675 mimic increased the expression of miR-675 and miR-675 inhibitor decreased the expression of miR-675.Importantly, the miR-675 mimic decreased ¦Â-gal staining and increased the numbers of proliferating cells, while the miR-675 inhibitor showed an opposite effect on ¦Â-gal staining and cell pr... | -- | -- | -- | -- | TGF¦Â1-p21 | Downregulation | Luciferase reporter assay//qRT-PCR//Western blot | Dual-luciferase reporter assays showed that the miR-675 mimic decreased the luciferase activity compared to the control. To confirm that TGF-¦Â1 is a target of miR675 in H9C2 cells, we transfected miR-675 mimic or inhibitor into these cells. We found that miR-675 mimic and inhibitor did not alter the expression of TGF-... | Human | L | delay aging | 30,889,706 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LNCTAM34A | 102724571 | ncRNA | HCT116 | Colon | Aging | Prevent | Cell viability assay//Knockdown//SA--gal activity assay | In addition, depletion of GUARDIN triggered cellular senescence.The effects of GUARDIN on cell viability were mirrored in the long-term survival of HCT116 cells in clonogenic assays and in their growth in nu/nu mice. | -- | -- | -- | -- | p53 | -- | Western blot//Cell viability assay//Knockdown | Although GUARDIN knockdown in the absence of p53 did not significantly affect cell viability, cell death was enhanced following induction of p53 . Conversely, overexpression of GUARDIN diminished the reduction in cell viability associated with p53 induction. Thus, although p53 controls the function of GUARDIN through r... | Human | HL | delay aging | 29,593,331 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR21 | 406991 | ncRNA | MCF-7 | -- | Breast cancer | Prevent | ELISA//Knockdown//MTT assay//SA--gal activity assay | Pre-miR-21 stimulated MCF-7 cell proliferation at the time points considered. In contrast, significant growth inhibition by ATRA was observed upon miR-21 silencing, indicating sensitization of MCF-7 cells. The effect of miR-21 silencing on ATRA-induced senescence was evaluated, using two molecular markers: -galactosid... | IL1B//ICAM-1//PLAT | Downregulation//--//Downregulation | Luciferase reporter assay//qRT-PCR//Western blot | We cloned the 3-UTR of the selected transcripts downstream of a luciferase reporter and evaluated the effect of miR-21 in 293T cells, which contain low levels of the miRNA (54) .MiR-21 inhibited the expression of the ICAM-1, PLAT, and IL1B constructs, indicating that they are direct targets.Forced expression of pre-miR... | -- | -- | -- | -- | Human | HL | delay aging | 21,131,358 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ACSL5 | 51703 | ncRNA | RT4,RT-112,Urotsa | Tumor tissue | Bladder cancer | Accelerate | SA--gal activity assay | Senescence-associated-¦Â-galactosidase activity was significantly associated with ACSL5 upregulation in tumours (p=0.03) and highest activity was also found in RT4 cells. RT112 and Urotsa showed no ¦Â-galactosidase activity, and in J82 enzyme activity was minimal. | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | delay aging | 23,348,389 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR146A | 406938 | ncRNA | HTM636,HTM1073 | -- | Aging | Prevent | BrdU assay//Flow cytometry//SA--gal activity assay | Production of SA-¦Â-gal and iROS was significantly decreased, and BrdU incorporation was significantly increased by miR-146a in both HTM cell lines. | PAI-1//IRAK1 | --//-- | BrdU assay | We investigated whether the observed effects of miR-146a on SA-¦Â-gal activity, iROS, and cell proliferation in senescent HTM cells were mediated by the downregulation of either the direct target IRAK1 or the secondary target PAI-1.Overexpression of both PAI-1 and IRAK1, lacking the miR-146a target site, inhibited the ... | -- | -- | -- | -- | Human | HL | delay aging | 20,053,980 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR138-1 | 406929 | ncRNA | HuH-7,HepG2,Hepatocyte | -- | Hepatocellular carcinoma | Accelerate | BrdU assay//SA--gal activity assay | Telomeric repeat amplification protocol (TRAP) assay, senescence-associated ¦Â-galactosidase assay and BrdU incorporation assay were performed 24 and 48 h after transfection. The results showed that miR-138 functioned to decrease telomerase activity, which in turn induced cell senescence and suppressed cell proliferati... | TERT | Downregulation | Western blot//qRT-PCR//Luciferase reporter assay | The binding site of miR-138 in the 3¡¯UTR of TERT gene was predicted by miRNA target prediction tools. The results showed that wild-type miR-138, but not mutant miR-138 (mutated in the seed-complementary sequence),can significantly suppress the luciferase activities of Huh7 cells transfected with wild-type TERT 3¡¯UTR ... | -- | -- | -- | -- | Human | L | delay aging | 28,258,280 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR101-1 | 406893 | ncRNA | MCF-7 | -- | Aging | Accelerate | SA--gal activity assay | Further, continuous (upto 72 hrs) over-expression of miR-101 depicted an enhanced induction of senescence(2.3-Fold¡À0.25). miR-101 inhibition with anti-miR-101 oligonu-cleotides depicted a profile (0.9-Fold 60.25) which matched with the control cells. | UBE2N//SMARCA4 | Downregulation//Downregulation | qRT-PCR | The validation of the two targets, UBE2N and SMARCA4, was established by measuring their endogenous cellular expression as well, which decreased significantly in over-expressing miR-101 cells. | -- | -- | -- | -- | Human | HL | delay aging | 25,353,636 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HOTAIR | 100124700 | ncRNA | WI-38,IDH4 | -- | Aging | Accelerate | Flow cytometry//SA--gal activity assay//qRT-PCR | The levels of senescent markers p53, p21 and p16 were elevated, and cells displayed the characteristic senescence- associated (SA) increase in G1 cell cycle compartment.That the increased HOTAIR was important for the implementation of senescence was evidenced by experiments in which silencing HOTAIR in IDH4 cells rever... | Ataxin-1//Snurportin-1 | Downregulation//Downregulation | Western blot//Co-IP | Interestingly,the interaction of Dzip3 and Ataxin-1, as well as the interaction of Mex3b and Snurportin-1, as assessed by co-IP followed by western blot (WB) analysis, was facilitated by HOTAIR overexpression; furthermore, the levels of Ataxin-1 and Snurportin-1 decreased after HOTAIR overexpression. | -- | -- | -- | -- | Human | L | delay aging | 24,326,307 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MALAT1 | 378938 | ncRNA | GBC-SD,SGC-996 | -- | Gallbladder cancer | Prevent | EdU assay//SA--gal activity assay//Transwell assay//Western blot | Our results indicated that when MALAT1 was silenced, the viability of the GBC-SD and SGC-996 cells was suppressed, and the expression of Ki67 and PCNA was reduced. Meanwhile, the capabilities of migration and invasion were inhibited, while the SA-¦Â-gal activity was promoted (p?<?0.05). | ABI3BP//EZH2 | Downregulation//Binding | qRT-PCR//Pull-down assay | We carried out the correlation analysis and found that the expression of MALAT1 and ABI3BP was negatively correlated.The binding of MALAT1 to EZH2 was further verified by RNA pull down. The results demonstrated that Bio-MALAT1-WT pull-down more EZH2 relative to that of the Bio-probe and Bio-MALAT1-MUT, suggesting that ... | -- | -- | -- | -- | Human | HL | delay aging | 31,174,563 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SNHG6 | 641638 | ncRNA | MGC803,MKN45 | -- | Gastric cancer | Prevent | Knockdown//SA--gal activity assay | The results showed that knockdown of SNHG6 in MGC-803 and MKN45 cells triggered an evident increase in the positive rate of senescent cells. | EZH2//p21 | Upregulation//Downregulation | Western blot//Knockdown | Knockdown of SNHG6 reduced the expression level of EZH2 and overexpression of SNHG6 also increased EZH2 expression. The results showed that the expression level of p21 was strikingly augmented in SNHG6-knockdown GC cells;In contrast with SNHG6 knockdown, overexpression of SNHG6 decreased p21 levels and increased EZH2 l... | JNK | -- | Western blot//Knockdown | -- | Human | L | delay aging | 30,031,062 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR127 | 406914 | ncRNA | WI-38,IMR-90 | -- | Aging | Accelerate | Cell counting//PI staining//SA--gal activity assay//Western blot | We observed that induced miR-127 expression caused a remarkable inhibition of cell proliferation and increased senescence-like phenotypes with positive staining of senescence-associated-¦Â-galactosidase (SA-¦Â-gal) in both WI-38 and IMR-90 cells.the senescence-like phenotype was associated with up-regulation of p53 and... | BCL6 | Downregulation | Western blot | Over-expression of miR-127 has markedly down-regulated BCL6 expression in both WI-38 and IMR-90 cells. | p53-p21 | Upregulation | Western blot | The depletion of BCL6 inhibited cell proliferation was associated with increased p53 and p21 expression . | Human | L | delay aging | 24,282,530 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR449B | 693123 | ncRNA | SNU638 | -- | Gastric cancer | Accelerate | Flow cytometry//SA--gal activity assay | Compared to negative control microRNAs, re-introduction of miR-449b strongly affected the proliferation of SNU638 cells and visual inspection of the cells indicated induction of apoptosis and cellular senescence. Flow cytometric analysis of propidium iodide-stained cells transfected with miR-449b showed a G1accumulatio... | -- | -- | -- | -- | p53 | Activation | Western blot | Western blot analysis showing an increase of the p53 protein upon miR-449 and positive control miR-34a re-introduction into SNU638 cells compared to RNA scrambled control as well as an activation of the p53 downstream target p21 and apoptosis markers cleaved CASP3 and PARP. | Human | HL | apoptosis | 21,418,558 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR150 | 406942 | ncRNA | Normal NK/T-cell Lymphoma cell line cell,HANK-1,MOTN-1,SNK-6 | -- | Malignant lymphoma | Accelerate | SA--gal activity assay//Southern blot analysis//TRAP assay | In addition, these cells stained positively for Ki-67 and senescence-associated beta-gal on day 21 after GFP selection and miR-150 transductants had a ¡®fried egg¡¯-like appearance, which is caused by senescence and is not seen in normal NK/T-cell lymphoma cells.Telomerase activity in miR-150 transductants (on day 21 a... | -- | -- | -- | -- | PI3K-Akt | Downregulation | Luciferase reporter assay//Western blot | Upon insertion of the wild-type 30-UTR of DKC1, PIK3AP1, AKT3 or AKT2 into the reporter, we observed significant reductions in luciferase activity with DKC1, PIK3AP1 and AKT2, but not in AKT3 (data not shown), as compared with cells transduced with empty vector(control vector), suggesting that DKC1, PIK3AP1 (data not s... | Human | L | apoptosis | 21,502,955 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR338 | 442906 | ncRNA | U251 | Brain | Malignant glioma | Accelerate | Flow cytometry//SA--gal activity assay | When compared with the blank group and the NC group, the cells were found relatively large in size with high degree of senescence in the miR-338-5p mimic group and the siRNA-FOXD1 group, while were small in size with low degree of senescence in the miR-338-5p inhibitor group.When compared with the blank group and the N... | -- | -- | -- | -- | FOXD1//MAPK | Downregulation//Downregulation | qRT-PCR//Western blot | When compared with the control group, the miR338-5p expression and the mRNA and protein expression of Bax in cells of each group decreased significantly, and the protein and mRNA expression of FOXD1, MEK-2, ERK-1, Bcl-2, DAF, and PCNA increased obviously (p<0.05). | Human | HL | apoptosis | 30,225,541 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR195 | 406971 | ncRNA | H1299,H1993,H358 | -- | Lung cancer | Accelerate | Flow cytometry//SA--gal activity assay | We observed significantly more cells in the G1 phase after miR-195 transfection, suggesting that miR195 causes arrest of NSCLC cells in the G1 phase.We found that miR-195 significantly increases the number of senescent cells, as measured by ¦Â-galactosidase staining assay . | CCND3//BIRC5 | Downregulation//Downregulation | Luciferase reporter assay//Western blot//qRT-PCR | We confirmed that mRNA and protein levels of CCND3 and BIRC5 are decreased by miR-195 and increased by miR-195 inhibitors in NSCLC cells.BIRC5 is predicted to contain one miR-195 target site in its 3¡äUTR, while CCND3 is predicted to contain two. We confirmed direct and specific regulation of BIRC5 and CCND3 by miR-195... | Rb | Activation | Western blot | We also found decreased levels of p-Rb by miR-195, indicating both activation of the retinoblastoma (Rb) pathway and senescence . | Human | HL | apoptosis | 29,416,000 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR380 | 494329 | ncRNA | Mammary epithelial cell | Mammary Gland | Neuroblastoma | Prevent | SA--gal activity assay | Tumor cells expressing activated HRAS plus control (empty vector or scrambled control) stained positive for senescence-associated ¦Â-galactosidase. In contrast, tumors expressing HRAS plus miR-380 or shRNA p53 did not express senescence markers . | p21 | Downregulation | Immunohistochemical staining//qRT-PCR | p21waf1 was increased in wild-type mouse mammary epithelial cells and tumor cells expressing activated HRAS plus control. In contrast, p21waf1 expression was lower in tumor cells that co-express HRAS and miR-380 or shRNA p53. | p53 | Downregulation | Western blot | Expression of miR-380-5p resulted in a significant ~40% decrease in basal p53 protein levels. UV irradiation led to a dose-dependent increase in p53 protein expression that was suppressed by the expression of miR-380-5p . | Human | L | apoptosis | 20,871,609 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR34A | 407040 | ncRNA | ECa-109 | -- | Endometrial cancer | Accelerate | Cell morphological analysis//SA--gal activity assay | After 4 days of incubation with miR-34a, we observed that the introduction of miR-34a in ECa-109 cells caused senescence-like phenotypes in most of the cells with positive staining for senescence associated ¦Â-galactosidase (SA-¦Â-Gal), and cell number decreased with enlarged cellular size and morphological changes com... | SIRT1//p53//p21 | Downregulation//Upregulation//Upregulation | Western blot | Western blot analysis revealed that the introduction of miR-34a (20 nM) decreased the expression of SIRT1 and increased the expression of p53 and p21 in ECa-109 cells; | -- | -- | -- | -- | Human | L | apoptosis | 26,523,671 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SNHG6 | 641638 | ncRNA | SK-BR-3,MDA-MB-231 | -- | Breast cancer | Prevent | Prevent | We found that the percentage of senescent cells was significantly increased in SNHG6 silenced SKBR-3 cells compared to that in scrambled siRNA transfected cells .SNHG6 silencing causes G1 cell cycle arrest in breast cancer cells and downregulation of Cyclin D1 and PCNA, two important factors in cell cycle progression, ... | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | apoptosis | 30,826,970 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR125A | 406910 | ncRNA | HBMEC | -- | Aging | Prevent | SA--gal activity assay | miR-125a-5p overexpression significantly decreased (by 50%) the percentage of senescence-associated ¦Â-galactosidase-positive HBMEC in both vehicle- and ox-LDL-treated groups. | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | apoptosis | 27,903,586 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR30D | 407033 | ncRNA | OVCAR-5,OWA42,MDA-MB-231,T47D,HCT116 | -- | Cancer | Prevent | Flow cytometry//SA--gal activity assay | We found that mir-30d inhibitor transfection led to a significant cell-cycle arrest at the G0/G1 phase.Finally, we observed that transfection of a mir-30d inhibitor not only significantly blocked cancer cell proliferation but also remarkably increased the number of the cells with typical senescence morphology. Four to ... | -- | -- | -- | -- | -- | -- | -- | -- | Human | HL | apoptosis | 22,058,146 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR1258 | 100302172 | ncRNA | H1299 | -- | Lung cancer | Accelerate | SA--gal activity assay | H1299 cells transfected with miR-1258 showed a strong blue SA-¦Â-gal staining, while there were only scattered SA-¦Â-gal positive cells in miR©\1258 inhibitor group. | -- | -- | -- | -- | GRb2-Ras-ERK | Downregulation | Western blot//qRT-PCR | GRB2 relative expression levels were down©\regulated with miR©\1258©\down©\regulated expression of si©\GRB2. Western blotting results showed that the expression levels of p©\c©\Raf, p©\Mek1/2 and p©\Erk1/2 were significantly decreased when miR©\1258 was overexpressed. However, the expression levels of p©\c©\Raf, p©\Mek... | Human | L | apoptosis | 30,069,987 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
VIM-AS1 | 100507347 | ncRNA | SW1116,SW480,HT29,SW48 | -- | Colorectal cancer | Prevent | DAPI staining//Flow cytometry//Knockdown//SA--gal activity assay | Flow cytometry data revealed that a significant increase in the proportion of cells in the G2/M phase and a decrease in the proportion of cells in the S phase in VIM- AS1 suppressed cells compared with the cells treated with scrambled siRNA, which implicated VIM- AS1 inhibition leads to G2/M arrest in colon cancer cell... | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | apoptosis | 29,656,793 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR192 | 406967 | ncRNA | HCT116,A549 | -- | Colorectal cancer | Accelerate | Flow cytometry//SA--gal activity assay | Whereas A549 cells (wt p53) were also retained in G1 by miR-192 and miR-215.HCT116 cells were transfected with control RNA or the microRNAs under study followed by SA-¦Â-Gal assay.MiR-192 and miR-215 were capable of inducing senescence to some extent but not as efficiently as miR-34a. | -- | -- | -- | -- | -- | -- | -- | -- | Human | HL | apoptosis | 19,074,875 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR215 | 406997 | ncRNA | HCT116,A549 | -- | Colorectal cancer | Accelerate | Flow cytometry//SA--gal activity assay | Whereas A549 cells (wt p53) were also retained in G1 by miR-192 and miR-215.HCT116 cells were transfected with control RNA or the microRNAs under study followed by SA-¦Â-Gal assay. MiR-192 and miR-215 were capable of inducing senescence to some extent but not as efficiently as miR-34a. | -- | -- | -- | -- | -- | -- | -- | -- | Human | HL | apoptosis | 19,074,875 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR101-1 | 406893 | ncRNA | SPAC-1-L,HEC-50 | -- | Endometrial cancer | Accelerate | SA--gal activity assay//Western blot | Introduction of miR-101 in SPAC-1-L and HEC-50 cells caused senescence-like phenotypes, such as positive staining for SA-¦Â-gal and enlarged, flattened cell morphology. Furthermore, immunoblot analysis revealed that miR-101 overexpression markedly enhanced the expression of pro-apoptotic gene Bax, apoptosis marker clea... | EZH2//MCL-1//FOS | Downregulation//Downregulation//Downregulation | Knockdown//qRT-PCR//Western blot | In agreement with this, a negative correlation between endogenous miR-101 levels and EZH2, MCL-1 and FOS mRNA expression was found in EC cells .Next, we confirmed that endogenous mRNA and protein levels of these genes were downregulated in 101-transfected SPAC-1-L cells . Knockdown of miR-101 by AS-101 conversely induc... | -- | -- | -- | -- | Human | HL | apoptosis | 25,153,722 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR155 | 406947 | ncRNA | HUVEC | -- | Aging | Accelerate | SA--gal activity assay//Western blot//qPCR | Determination of cellular senescence of HUVECs was conducted using 2 indicators¨C anti-SMP-30 and SA ¦Â-Gal staining ¨C and TNF-¦Á significantly reduced SMP-30 protein expression by almost 50% and enhanced SA ¦Â-Gal staining by nearly 2-fold. Then, the role of miR-155 in senescence of HUVECs was assessed, and the resul... | -- | -- | -- | -- | SIRT1-FOXO1-p53-p21 | -- | SA-¦Â-gal activity assay//Western blot//Knockdown | Thus, the downstream signaling targets of SIRT1, including the protein levels of acetylated FoxO-1, acetylated p53, and p21, were also determined. Knockdown of miR-155 decreased p21, Ac-p53, and Ac-FoxO-1 protein expression, and SIRT1 silencing reversed this effect.Then, we assessed whether HUVEC proliferation and sene... | Human | L | apoptosis | 31,752,013 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
MIR34A | 407040 | ncRNA | A549 | -- | Idiopathic Pulmonary Fibrosis | Accelerate | SA--gal activity assay//qRT-PCR | It was found that cells overexpressing miR-34a,miR-34b, or miR-34c had a relative increase in the numbers of cells expressing SA-¦Âgal activity.In addition, levels of mRNA expression of p16 and p21 were increased between 1¨C1.9 fold in A549 cells expressing miR-34s. | -- | -- | -- | -- | -- | -- | -- | -- | Human | HL | telomere attrition | 27,362,652 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MIR34A | 407040 | ncRNA | HCT116,RKO | -- | Colorectal cancer | Accelerate | Cell proliferation assay//SA--gal activity assay | We observed that introduction of miR-34a in HCT 116 cells caused senescence-like phenotypes with positive staining for senescence-associated ¦Â-galactosidase (SA-¦Â-gal) and enlarged cellular size.RKO cells also showed similar morphological changes with enlarged cellular size by miR-34a introduction,although few SA-¦Â-... | -- | -- | -- | -- | E2F//p53 | Downregulation//Upregulation | Western blot | We also observed that p53 and p21 started to accumulate at 2 and 4 h, respectively, and the accumulation continued until 48 h after treatment.As expected, LoVo and RKO cells increased expression of miR-34a similar to HCT 116 cells, but DLD1 and HT29 cells showed no change, like the HCT 116 p53/ cells. Accumulation of p... | Human | HL | deregulated nutrient sensing | 17,875,987 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR29A | 407021 | ncRNA | MEF | Embryo | Aging | Accelerate | SA--gal activity assay | Increased abundance of miR-29 (represented miR-29a and miR-29c hereinafter) in early passaged cells (PD4) accelerated senescence whereas decreased amounts of miR-29 in late passaged cells (PD8) delayed senescent phenotypes. | H4K20me3 | Downregulation | Western blot | Furthermore, forced expression or inhibition of miR-29, by individual transfection of miRNA mimics (M-miR-29) or inhibitors (I-miR-29a and I-miR-29c), resulted in decreased or increased H4K20me3 abundance, respectively. Gain of function of miR-29 via lentiviral infection led to reduced protein levels of Suv4-20h and H4... | -- | -- | -- | -- | Human | L | epigenetic alterations | 29,967,491 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TERC | 7012 | ncRNA | Squamous cell | Tumor tissue | Skin cancer | Accelerate | Cell proliferation assay//Telomere length assay | The percentage of apoptotic cells in Terc+/+ tumors averaged 1.1%. In contrast, the percentage of apoptotic cells in Terc-/- tumors was 5.5% (P < 0.04). Compared with Terc+/+ tumors.Average telomere length ratios were significantly lower in tumors compared with normal mucosa (2.1 vs. 0.78 for Terc+/+, 2.0 vs. 0.6 for G... | -- | -- | -- | -- | -- | -- | -- | -- | Human | HL | genomic instability | 21,593,138 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR22 | 407004 | ncRNA | MCF-7,MDA-MB-231,SiHa | -- | Aging | Accelerate | SA--gal activity assay//Western blot//qPCR | Introduction of miR-22 into cancer cells caused a senescence-like phenotype, as observed by the increased senescence-associated ¦Â-galactosidase (SA-¦Â-gal) activity.Thus, miR-22¨Cmediated downregulation of MDC1 expression is a common mechanism in aging cells and is utilized indiverse and widespread tissue types in mam... | MDC1//Akt1 | Downregulation//-- | qPCR//Western blot//Luciferase repoter assay | Using real-time quantitative PCR (qPCR), we found that MDC1 mRNA was reduced more than 50% when miR-22 was overexpressed,indicating that miR-22 posttranscriptionally downregulates MDC1, probably by promoting both mRNA decay and inhibiting translation.We found that inhibition of endogenous miR-22 led to an increase in M... | -- | -- | -- | -- | Human | HL | genomic instability | 25,627,978 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
BMP2 | 650 | protein coding | RasV12 | -- | Aging | Accelerate | Knockdown//SA--gal activity assay | Bmp2-knocked-down RasV12 cells escaped from senescence with decreased number of SA-¦Âgal(+) cells compared to RasV12 cells.The cells showed increased number of SA-¦Âgal(+) cells in dose-dependent manner,even to the level of RasV12 cells when rBMP2 was at 200 ng/mL. | Smad1//Smad6 | Upregulation//Upregulation | Knockdown//Western blot//CHIP-seq | Smad1 target genes upregulated most by rBMP exposure included Smad6, which was upregulated by 4.5-fold in MEF. | -- | -- | -- | -- | Human | HL | cellular senescence | 22,072,987 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR1827 | 100302217 | ncRNA | HCT116,RKO | -- | Colorectal cancer | Accelerate | Knockdown//SA--gal activity assay | MiR-1827 enhanced p53-mediated senescence in HCT116 cells treated with Doxorubicin.MiR-1827 enhanced p53-mediated senescence in RKO cells treated with Doxorubicin. miR-1827 inhibitor reduced p53-mediated senescence in HCT116 cells treated with Doxorubicin.Compared with control inhibitor, miR-1827 inhibitor significantl... | MDM2//p53 | Downregulation//Upregulation | Western blot | miR-1827 reduced MDM2 protein levels and increased p53 protein levels in HCT116 cells treated with Doxorubicin (Dox). | -- | -- | -- | -- | Human | HL | apoptosis | 26,840,028 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR23A | 407010 | ncRNA | PBMC | Blood | Coronary artery disease | Accelerate | FISH | Levels of miR-23a were negatively correlated with levels of RTL in all subjects ( miR-23a vs. RTL, r = -0.58, P < 0.01). | TRF2 | Downregulation | Flow cytometry | The miR-23a mimic transfection resulted in a decrease in levels of TRF2 compared with the mock transfection.The miR-23a inhibitor transfection also resulted in an increase in levels of TRF2 compared with the mock transfection. | -- | -- | -- | -- | Human | HL | telomere attrition | 28,646,123 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR494 | 574452 | ncRNA | AsPC-1,PANC-1 | -- | Pancreatic cancer | Accelerate | Flow cytometry//PI staining//SA--gal activity assay | MiR-494 induced the G1-phase arrest of AsPC-1 and PANC-1 cells (measured by propidium iodide (PI) staining and flow cytometry). (f) MiR-494 induced senescence of AsPC-1 and PANC-1 cells (measured by ¦Â-Gal staining).As well as increased the proportion of cells in the G1 phase in AsPC-1 (63.3¡À3.1% vs 73.7¡À2.5%, P<0.05... | c-Myc//SIRT1 | Downregulation//Downregulation | qRT-PCR//Western blot | The qRT-PCR and western blot results confirmed that miR-494 restoration led to the downregulation of c-Myc and SIRT1 expression, whereas the inhibition of miR-494 expression increased c-Myc and SIRT1 expression. | -- | -- | -- | -- | Human | L | apoptosis | 25,965,392 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR19B1 | 406980 | ncRNA | Hela,MCF-7 | -- | Cancer | Prevent | Flow cytometry//SA--gal activity assay | Further investigation of miR-19b's effect on cell cycle arrest revealed that overexpression of exogenous miR-19b caused exiting from the G1 phase and entry into S or G2/M phase in both Hela and MCF7 cells .¦Â-galactosidase staining showed that cellular senescence was reduced when miR-19b was overexpressed in both Hela... | p53 | Downregulation | Western blot//qRT-PCR | miR-19b was transfected into Hela cells and p53 levels of both transcriptional and translational were examined after 48 h. Western blot and qRT-PCR showed that p53 protein levels decreased by 50%, while mRNA levels were not altered. Similarly, the decrease of endogenous p53 protein was observed in both MCF7 and Huh7 ce... | -- | -- | -- | -- | Human | L | apoptosis | 24,742,936 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR30D | 407033 | ncRNA | 293T,H1299,HCT116 | -- | Cancer | Prevent | Flow cytometry//SA--gal activity assay | In our experiment, Gadd45¦Á was down-regulated along with p53 in 293T cells transfected with both miR-25 and miR-30d and a cell cycle analysis showed that fewer cells were arrested at the G2-M phase than in the control. We then performed a cell cycle analysis and found that fewer cells were arrested at the G1-S phase (... | p53//p21 | Downregulation//Downregulation | Western blot | We found that both miR-25 and miR-30d down-regulated the expression of the ectopic p53 gene carrying a wt 3¡¯UTR but not the one with a mutant. The expression of both p21 and Bax was either reduced or minimally changed, following p53 expression. These results suggest that miR-25 and miR-30d regulate cellular senescenc... | -- | -- | -- | -- | Human | L | apoptosis | 20,935,678 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR25 | 407014 | ncRNA | 293T,H1299,HCT116 | -- | Cancer | Prevent | Flow cytometry//SA--gal activity assay | In our experiment, Gadd45¦Á was down-regulated along with p53 in 293T cells transfected with both miR-25 and miR-30d and a cell cycle analysis showed that fewer cells were arrested at the G2-M phase than in the control. We then performed a cell cycle analysis and found that fewer cells were arrested at the G1-S phase (... | p53//p21 | Downregulation//Downregulation | Western blot | We found that both miR-25 and miR-30d down-regulated the expression of the ectopic p53 gene carrying a wt 3¡¯UTR but not the one with a mutant. The expression of both p21 and Bax was either reduced or minimally changed, following p53 expression. These results suggest that miR-25 and miR-30d regulate cellular senescenc... | -- | -- | -- | -- | Human | L | apoptosis | 20,935,678 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR339 | 442907 | ncRNA | HCT116 | -- | Colorectal cancer | Accelerate | SA--gal activity assay | MiR-339-5p enhanced p53-mediated senescence in HCT116 cells treated with Doxorubicin.The miR-339-5p inhibitor reduced p53-mediated senescence in HCT116 cells treated with Doxorubicin. | MDM2//p21//p53 | Downregulation//Upregulation//Upregulation | Western blot | MiR-339-5p decreased MDM2 protein levels and increased the p53 protein accumulation and transcriptional activity toward p21 in response to stress in HCT116 cells. (C) MiR-339-5p decreased MDM2 protein levels and increased p53, p21 protein levels in response to stress in RKO cells. | -- | -- | -- | -- | Human | L | apoptosis | 25,193,859 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR200C | 406985 | ncRNA | HUVEC | -- | Aging | Accelerate | SA--gal activity assay | In HUVEC transduced with miR-200c the percentage of SA-¦Â-gal-positive cells was strongly increased compared with control. | ZEB1 | Downregulation | Western blot | As expected, ZEB1 protein was downmodulated by miR-200c overexpression. | -- | -- | -- | -- | Human | L | apoptosis | 21,527,937 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR34A | 407040 | ncRNA | A549,BEAS-2B | -- | Idiopathic pulmonary fibrosis | Accelerate | BrdU assay//Flow cytometry//SA--gal activity assay//Western blot//qRT-PCR | MiR-34a was potent in inducing senescence of human lung epithelial A549 cells, as indicated by elevated senescence-associated ¦Â-galactosidase activity and increased expression of senescence markers p21 and PAI-1 in miR-34a transfected lung epithelial cells. Consistent with this senescent phenotype, miR-34a transfected... | SIRT1 | Downregulation | qRT-PCR | We confirmed that Sirt1 expression was decreased in lung epithelial cells that were transfected with miR-34a. | -- | -- | -- | -- | Human | L | apoptosis | 27,979,858 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MIR34A | 407040 | ncRNA | Chondrocyte | Bone | Osteoarthritis | Accelerate | CCK-8 assay//Flow cytometry//SA--gal activity assay | Cells characterized by positive SA-¦Â-gal were enhanced in chondrocytes that underwent transfection with the miR-34a mimic.Compared to the TRAIL alone treatment group, the inhibitor of miR-34a suppressed the number of apoptotic cells.The miR-34a mimic transfection remarkably suppressed the growth of these cells. | DLL1 | Downregulation | Luciferase reporter assay//Western blot | In order to explore the interaction between miR-34a and the DLL1 3¡ä-UTR, the miR-34a binding region was mutated in the DLL1 3¡ä-UTR. Subsequent to luciferase vector co-transfection with DLL1 3¡ä-UTR as well as the miR-34a mimic, the miR-34a mimic was discovered to be unable to inhibit expression of luciferase. The fin... | PI3K-Akt | Downregulation | Western blot | He findings revealed that the level of total AKT and p-AKT declined in the groups that underwent miR-34a transfection. | Human | L | apoptosis | 30,048,987 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR34C | 407042 | ncRNA | KG-1a | -- | Leukemia | Accelerate | EdU assay//Flow cytometry//SA--gal activity assay//Western blot//qRT-PCR | Forced expression of miR-34c-5p resulted in a decreased cell number, proliferation index, and percentage of EdU+ cells.. Increased miR-34c5p induced an increase in the number of G0/G1 phase cells and decreased cell cycle-associated protein levels.Up-regulation of miR-34c-5p failed to induce apoptosis but resulted in si... | RAB27B | Binding | qPCR//Western blot//Luciferase reporter assay | Using qPCR and Western blotting, we further confirmed that RAB27B mRNA and protein levels were decreased in 34cOE-KG-1a cells.We selected one of the most likely binding sites according to the folding energy and P- value parameters provided by rna22 and performed a luciferase reporter assay. We found that co-transfectio... | -- | -- | -- | -- | Human | HL | delay aging | 29,479,064 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MIR106B | 406900 | ncRNA | MTMEC | -- | Breast cancer | Prevent | EdU assay//SA--gal activity assay | Overexpression of the miR-106bB25 cluster allowed cells to bypass doxorubicin-induced senescence and increased the capacity of MTMEC cells to generate doxorubicin-resistant cells. | EP300 | Binding | Luciferase reporter assay | To experimentally confirm that EP300 mRNA was a target of the miR-106bB25 cluster, we used a luciferase reporter with the 30 -UTR of EP300 and transiently transfected either control or cells overexpressing the cluster or individual miRs. In all cases, luciferase expression from the plasmid containing the EP300 30 -UTR ... | -- | -- | -- | -- | Human | HL | delay aging | 24,270,410 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR31 | 407035 | ncRNA | MDA-MB-231,MCF-7,MRC-5 | -- | Aging | Accelerate | EdU assay//Immunostaining//SA--gal activity assay | The data showed that indeed, miR-31 overexpression increased SA-¦Â-gal positive cells and decreased EdU positive cells indicating that miR-31 is a potent inducer of cell senescence. The role of miR-31 in senescence was further confirmed by examining ¦ÃH2AX foci formation, which is another marker of cell senescence. The... | BMI1 | Downregulation | Western blot | We found that miR-31 overexpression leads to repression of BMI1 and its inhibitor up-regulates BMI1.miR-31 overexpression also led to significant down-regulation of BMI1. | -- | -- | -- | -- | Human | HL | cellular senescence | 25,737,447 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DPP4 | 1803 | protein coding | HUVECs | -- | Aging | Accelerate | Immunochemical staining//SA--gal activity assay//Western blot | The fraction of senescence-associated ¦Â-galactosidase (SA-¦Â-gal) positive cells was increased with aging, whereas DPP4 inhibition mitigated this enhancement. In addition, immunohistochemical staining and western blot analysis revealed that the aging markers, including p53 and p21, were increased with advancing age, w... | -- | -- | -- | -- | AMPK-SIRT1-Nrf2 | Activation | Immunochemical staining//Western blot//Immunofluorescence | Immunohistochemical staining and western blot analysis revealed that SIRT1 and AMPK¦Á expression, as well as phosphorylation level of AMPK¦Á, was decreased with aging, and that DPP4 inhibition was able to restore these changes in aging aortas. As observed in in vivo studies, SIRT1 and AMPK¦Á expression, as well as - ph... | Human | L | cellular senescence | 32,251,672 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PIM1 | 5292 | protein coding | Cardiomyocytes | -- | Aging | Prevent | Fluorescence quenching assay//RT-PCR | PIM1 cells contained 1.55- fold longer telomeres than GFP cells after three passages as revealed by quantitative RT-PCR.Telomeres were 27% longer in PIM1 myocardium and 31% shorter in Pim1-KO hearts compared to NTg as revealed by qRT¨CPCR.Telomere fluorescence intensity was 28% greater in PIM1 cardiomyocytes and reduce... | -- | -- | -- | -- | TGF¦Â | Downregulation | Western blot//qRT-PCR//Immunoblotting(ÃÏÀö¼ÓµÄ) | In the presence of TGFb1 agonist, PIM1 exhibited a 41% reduction in pSMAD2 levels compared to GFP as evaluated by immunoblotting. Inhibitory effects of PIM1 on TGFb signalling were confirmed by expression of canonical downstream target SERPINE1 and non-canonical target N-CADHERIN as measured via qRT-PCR. PIM1 displayed... | Human | L | cellular senescence | 32,176,281 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IRX5 | 10265 | protein coding | SW480 | -- | Aging | Accelerate | SA--gal activity assay | Indeed approximately 60% to 70% of IRX5 overexpression cells exhibited positivity for the se- nescence hallmark, SA ¦Â gal compared to control ones. | -- | -- | -- | -- | ATM | Activation | Immunofluorescence//RT-PCR//Western blot | As we expected the immunofluorescence staining of ATM increased in IRX5 overexpression cells compared with that in controls. To confirm the inactivation of the ATM pathway by siRNA, real time PCR was performed. According to the efficiency of siRNA, we chose si1 in SW480 and si4 in DLD 1. Meanwhile, the inhibition of A... | Human | L | cellular senescence | 32,162,364 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MTOR | 2475 | protein coding | Fibroblasts | -- | Aging | Accelerate | SA--gal activity assay//Western blot | Serum-starved fibroblasts exposed to R showed lowered CDNK1A and CDKN2A protein levels and decreased SA-GLB1/¦Â-gal activity.RICTOR silencing suppressed AKT1 phosphorylation at Ser473 along with repression of myofibroblast differentiation inhibition of CDKN1A and CDKN2A expression, and inhibition of SA-GLB1/¦Â-gal acti... | AKT1 | Upregulation | Western blot//SA-¦Â-gal activity assay | RICTOR silencing suppressed AKT1 phosphorylation at Ser473 along with repression of myofibroblast differentiation inhibition of CDKN1A and CDKN2A expression, and inhibition of SA-GLB1/¦Â-gal activity. | -- | -- | -- | -- | Human | L | cellular senescence | 31,931,659 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
HNRNPF | 3185 | protein coding | hMSCs | -- | Aging | Prevent | CCK-8 assay//Cell cycle analysis//Colony formation assay//Immunofluorescence//SA--gal activity assay | Knockdown of hnRNP F in 5PDs of hMSCs largely accelerated cell senes- cence, which indicated by the dramatic increase of SA-¦Â-gal activity.More severe retardation of cell proliferation was observed after knockdown of hnRNP H1 in hnRNP F KD HeLa cells. Furthermore, knockdown of both hnRNP H1 and H2 in hnRNP F KD HeLa c... | TCAB1//hTERC | Binding//Binding | Immunofluorescence//Biotinylated RNA pull down assay | The immunofluorescent signals of FLAG-hTERT overlapped with a specific Cajal bodies marker Coilin signals in the nuclei in both HeLa and U2OS control cells.The results showed that hnRNP F/H may form stable ribonucleoprotein complex with hTERC through direct binding. | -- | -- | -- | -- | Human | L | cellular senescence | 31,863,069 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CGRP | 796 | protein coding | NPCs | -- | Intervertebral disc degeneration | Accelerate | CCK-8 assay//Immunochemical staining//RT-PCR//Safranin O-fast green staining | To further explore the relationship between CGRP and its receptors, CALCRL and RAMP1, and age, mice with different age of months were further used. As shown in safranin O-fast green staining, the shape of IVD tissue was collapsed in aged mice at 12 months and 18 months compared with 6 months, suggesting the interverteb... | -- | -- | -- | -- | MAPK//NF-¦ÊB | Activation//Activation | Western blot//Immunofluorescence | Western blot demonstrated that CGRP could dose-dependently enhance the phosphory- lation of MAPK. Besides, NF-¦ÊB signaling pathway was also concentration-dependently activated by CGRP, and this activated effect was achieved through the phosphorylation of I¦ÊB-¦Á. Immunofluorescence results suggested that the nucleus t... | Human | L | loss of proteostasis | 34,987,701 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PRKG1-AS1 | 100506939 | ncRNA | Myoblasts | Skeletal muscle | Aging | Accelerate | CCK-8 assay//Cell viability assay//Flow cytometry//Western blot//qRT-PCR | CCK-8 assay showed that knock-down of PRKG1-AS1 could significantly increase cell viability in a time-dependent manner. Besides, flow cytometry demonstrated that cell apoptosis was significantly decreased by knocking-down of PRKG1-AS1 compared with the model group. In order to validate the effect of PKG1-AS1 at molecul... | MyoD//MyoG//Mef2c | Downregulation | qRT-PCR//Western blot | In order to validate the effect of PKG1-AS1 at molecular level, we detected the mRNA and protein expression of muscle regulatory factors, including MyoD, MyoG, Myf2c and Myf5. These four factors were significantly decreased in the dexamethasone-induced muscle atrophy cell model (P < 0.05). After transfection with si-PR... | -- | -- | -- | -- | Human | HL | apoptosis | 34,051,073 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MIR99B | 407056 | ncRNA | Chondrocyte | -- | Osteoarthritis | Accelerate | Western blot | We then explored the role of miR-99b-5p in OA development. Increased MMP13 and decreased COL2 were detected in mimics-treated chondrocytes, accompanied by enhanced senescence-related hallmarks P16, P21, and P53. | MFG-E8 | Downregulation | Western blot | We found inhibited expression of MFG-E8 in cells treated with miR-99b-5p mimics and upregulated expression in cells treated with miR-99b-5p inhibitor. | p65 NF-¦ªb | Activation | Immunofluorescence//Western blot | We found that MFG-E8 treatment rescued the phosphorylation of p65 NF-¦ÊB signaling, while neutralizing MFG-E8 significantly enhanced p65 phosphorylation both in cartilage and in synovium post OA surgery. In vitro studies in murine primary chondrocytes and RAW264.7 cells con- firmed the suppressive effect of MFG-E8 in p... | Human | L | apoptosis | 34,031,369 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MFGE8 | 4240 | protein coding | Chondrocyte | -- | Osteoarthritis | Prevent | Immunofluorescence//SA--gal activity assay//Western blot | ¦Â-galactosidase staining revealed that rmMFG-E8 markedly rescued the senescence phenotype induced by IL-1¦Â in primary murine chondrocytes. Senescence-related hallmarks P16, P21 and P53 were significantly downregulated after ectopic application of MFG-E8 in IL-1¦Â-pretreated primary chondrocytes, while MFG-E8 loss str... | -- | -- | -- | -- | p65 NF-¦ÊB | Downregulation | Immunofluorescence//Immunoblotting | We found that MFG-E8 treatment rescued the phosphorylation of p65 NF-¦ÊB signaling, while neutralizing MFG-E8 significantly enhanced p65 phosphorylation both in cartilage and in synovium post OA surgery. We found that the NF-¦ÊB pathway inhibitor JSH-23 partially reduced MFG-E8 loss-induced expression of P53, P21 and P... | Human | L | apoptosis | 34,031,369 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TBK1 | 29110 | protein coding | NPCs | -- | Intervertebral disc degeneration | Prevent | SA--gal activity assay//TUNEL assay//Western blot | We markedly found that cells transfected with lentivirus-TBK1 (Lv- TBK1) remarkably exhibited less p16INK4a (p16) activity than cell transfected with lentivirus-Control (Lv-Ctrl) at passage 15, show- ing that TBK1 exerted an enormous function on NPCs senescence. The p16 and cleaved caspase-3 (CC3) expression levels wer... | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | apoptosis | 34,026,282 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CDK4 | 1019 | protein coding | BxPC-3,Panc-1,MiaPaCa-2 | -- | Aging | Prevent | SA--gal activity assay | The ¦Â-galactosidase assay was used to determine senescence following treatment with LEE011 and MEK162. Combined inhibition resulted in a significant increase in ¦Â-galactosidase staining when compared to monotherapy in all cell lines, suggesting that combined inhibition of CDK4/6 and MEK with LEE011 and MEK162, respe... | pERK | Upregulation | Western blot | We observed reduced phosphorylated ERK (pERK) levels at all doses and in a time-dependent manner. Finally, ctreatment with MEK162 and LEE011 alone and in combination resulted in suppressing both pERK and pRb levels in all cell lines. | -- | -- | -- | -- | Human | L | apoptosis | 34,001,634 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CDK6 | 1021 | protein coding | BxPC-3,Panc-1,MiaPaCa-2 | -- | Aging | Prevent | EdU cell proliferation assay//Flow cytometry//SA--gal activity assay | The ¦Â-galactosidase assay was used to determine senescence following treatment with LEE011 and MEK162. Combined inhibition resulted in a significant increase in ¦Â-galactosidase staining when compared to monotherapy in all cell lines, suggesting that combined inhibition of CDK4/6 and MEK with LEE011 and MEK162, respec... | pERK | Upregulation | Western blot | We observed reduced phosphorylated ERK (pERK) levels at all doses and in a time-dependent manner. Finally, ctreatment with MEK162 and LEE011 alone and in combination resulted in suppressing both pERK and pRb levels in all cell lines. | -- | -- | -- | -- | Human | L | apoptosis | 34,001,634 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
BRAF | 673 | protein coding | HPCs,LCH cells | -- | Langerhans cell histiocytosis | Accelerate | ELISA//Immunofluorescence//RNA-seq//RT-PCR//SA--gal activity assay | HPCs isolated from BRAF-V600EScl+ mice were positive for SA¦ÂGal; and pro- duced SASP-associated proteins, all features consistent with a senescent state. LCH cells isolated from peripheral tissues of BRAF-V600EScl+ mice were also in a senescent state, as shown by reduced Ki-67 expression, expression of Cdkn2a, SA¦ÂGal... | -- | -- | -- | -- | mTOR | Activation | ELISA//Flow cytometry | We first confirmed that inhibition of the mTOR pathway was sufficient to reduce the production of inflammatory cytokines by BRAF-V600E+ senescent HPCs in vitro. And in line with our hypothesis, SASP inhibition significantly reduced BRAF-V600E+ HPC skewing into MNPs in vitro. Rapamycin treatment also partially reduced e... | Human | HL | apoptosis | 33,958,797 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
TNF | 7124 | protein coding | A375,HT29 | -- | Melanoma | Accelerate | SA--gal activity assay | Characteristic enlarged senescent cells containing blue-dyed precipitates indicating increased senescence-associated ¦Â- galactosidase activity appeared in both melanoma lines A375hTNFa and M4BeuhTNFa. Senescence induction was observed also in parental melanoma cells treated with recombinant human TNF¦Á protein. In col... | TRAIL//IL6 | Upregulation//Upregulation | qRT-PCR | CSCs- like markers remained unchanged In engineered melanoma cells A375hTNFa, significant overexpression of inflammatory cytokine IL6 was in- duced. Overexpression of TNF¦Á in cells HT29hTNFa significantly stimulated expression of apoptosis-inducing ligand TRAIL. | -- | -- | -- | -- | Human | L | apoptosis | 33,957,885 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ATG5 | 9474 | protein coding | NPCs | -- | Intervertebral disc degeneration | Prevent | SA--gal activity assay//Western blot | IL-1¦Â-increased percentage of senescence-associated beta-galactosidase (SA-¦Â-gal)-positive cells. Increased p16/INK4A, p21/WAF1/CIP1, and p53 expression, indicating senescence induction. | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | apoptosis | 33,921,398 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DKC1 | 1736 | protein coding | A549 cells,PC-9 cells | -- | Aging | Prevent | SA--gal activity assay//Western blot | There was more senescence associated ¦Â-galactosidase positive cells in DKC1 silenced A549 and PC-9 cells, and the expression of cell senescence and apoptosis marker P21 and DNA damage marker ¦ÃH2A. X are higher in A549 and PC-9 cells with DKC1 downregulation compared to control cells. | TERC | Upregulation | SA-¦Â-gal activity assay//Western blot//qPCR//Spearman's rank correlation analysis | Both the level of TERC and telom- erase activity were significantly decreased in DKC1 silenced A549 and PC-9 cells. In accordance with this phenomenon, DKC1 downregulated A549 and PC-9 cells showed reduced length of tel- omere. There was more senescence associated ¦Â-galactosidase positive cells in DKC1 silenced A549 ... | -- | -- | -- | -- | Human | HL | cellular senescence | 33,879,171 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CXCR2 | 3579 | protein coding | LL2 cells,H460 cells | -- | Lung cancer | Prevent | CCK-8 assay//SA--gal activity assay//Western blot//qRT-PCR | Selective inhibitor of CXCR2, SB225002, was confirmed to inhibit the proliferation of lung cancer cells in a both time-dependent and dose-dependent manner. To investigate the role of CXCR2 in tumor cell senescence, the expres- sion of SA-¦Â-gal was detected while using SB225002 on LL2 and H460 cells. After 24 h, the re... | -- | -- | -- | -- | p38-ERK MAPK | Activation | Western blot | After using SB225002 and CXCL2 on LL2 cells, p38/ERK MAPK signaling pathway was found involved in CXCR2-associated signaling pathway. The levels of p38 and ERK proteins phosphorylation were obviously al- tered, whereas p-JNK almost remained unchanged during activation or inhibition of CXCR2. | Human | HL | apoptosis | 33,814,009 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
BMP5 | 653 | protein coding | Chondrocytes | -- | Osteoarthritis | Accelerate | SA--gal activity assay//Western blot//qRT-PCR | We then performed SA-¦Â-gal staining assay to determine the role of BMP5 in OA-related chondrocyte senescence. IL-1¦Â-treated BMP5 knockdown chondro- cytes showed significantly lower SA-¦Â-gal activity than the corresponding controls. Western blotting analysis showed that p16, p21, HMGB1, and p53 protein levels were si... | -- | -- | -- | -- | p38-ERK | Activation | Western blot | We analyzed the status of the p38/ERK signaling pathway in control and BMP5-silenced chondrocytes subjected to IL-1¦Â treatment by western blotting. The levels of total and phosphorylated p38 and ERK1/2 proteins were significantly higher in the IL-1¦Â- treated control chondrocytes compared to the IL-1¦Â treated BMP5-si... | Human | L | apoptosis | 33,744,859 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
CRY1 | 1407 | protein coding | UMUC3 Res cells,EJ Res cells | -- | Bladder cancer | Prevent | SA--gal activity assay//Western blot//qPCR | After CRY1 knockdown, p21 mRNA expression was significantly downregulated, but its protein expression was not significantly changed in both Res cells. The p53 mRNA expression did not change significantly in EJ Res cells, but was significantly increased in UMUC3 Res cells. Moreover, its protein expres- sion was signific... | P53 | Downregulation | Western blot//qPCR | The p53 mRNA expression did not change significantly in EJ Res cells, but was significantly increased in UMUC3 Res cells. Moreover, its protein expres- sion was significantly enhanced after CRY1 knockdown in both cell lines. | -- | -- | -- | -- | Human | L | apoptosis | 33,650,658 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
MIR340 | 442908 | ncRNA | HT22 | -- | Alzheimer's disease | Prevent | MTT assay//SA--gal activity assay | Compared with untreated HT22 cells, the viability of A¦Â42 induced cell viability was decreased, the apoptotic rate was increased, and intracellular ¦Â galactose deposition was increased, which suggested accelerated cellular senescence, but these signs were alle- viated after POT1 downregulation.£¨É¾³ý£¿£©Compared with... | POT1 | Downregulation | Dual-Luciferase reporter assay//qRT©\PCR//SA-¦Â-gal activity assay | A dual luciferase reporter vector was con- structed to validate the targeted binding relationship between miR 340 5p and POT1. MiR-340-5p was overexpressed using agomiRNA in A¦Â42 induced HT22 cell, and intracellular POT1 level was decreased after overexpression of miR-340-5p. Compared with cells in the A¦Â42 group, ce... | -- | -- | -- | -- | Human | L | cellular senescence | 33,624,913 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT6 | 51548 | protein coding | LFH cells | -- | Lumbar spinal stenosis | Prevent | SA--gal activity assay//qRT-PCR | SIRT6 overexpression significantly reduced the frequency of SA-¦Â-gal-positive LFH cells to 11.8%. Trends in the expression of senescence- related genes including p16INK4a, MMP3, and long interspersed nuclear element 1 were consistent with frequencies of SA-¦Â-gal-positive cells, with the exception of L1, which was inh... | hTERT | Upregulation | SA-¦Â-gal activity assay//qRT-PCR | SIRT6 overexpression significantly reduced the frequency of SA-¦Â-gal-positive LFH cells to 11.8%, whereas hTERT knockdown increased this frequency to 28.4%. Importantly, hTERT knockdown in SIRT6-overexpressing cells reversed the beneficial impact of SIRT6 overexpression and increased the frequency of SA-¦Â-Gal positi... | -- | -- | -- | -- | Human | HL | cellular senescence | 33,568,575 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MIR130A | 406919 | ncRNA | SH-SY5Y | -- | Aging | Prevent | Western blot | Overexpression of miR-130a in D-galactose (D-gal)-induced SH-SY5Y cell senescence model attenuated D-gal-induced impaired autophagy and cell senescence, demonstrated by decreased levels of LC3, Ac-p53, p21 and increased p62 | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | cellular senescence | 33,964,346 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AHNAK | 79026 | protein coding | BJ cells | -- | Aging | Prevent | SA--gal activity assay | To induce senescence by Nutlin-3, BJ cells were seeded at low density, and then transfected with indicated siRNA. Subsequently, cells were left treated with DMSO or Nutlin-3 (20 mM) for indicated days, and SA-b galactosidase assay is performed as described previously. | 53BP1 | Binding | IP//Western blot | Western blot (WB) using anti-mCherry and anti-AHNAK antibodies after immunoprecipitation (IP) with IgG or Anti-AHNAK beads as indicated. | p53 | Downregulation | Western blot | Immunoblot analysis of BJ fibroblast following transfection with control or indicated siRNA. Cell lysates prepared from untreated and NCS-treated cells were analyzed using immunoblot using the specified antibodies. | Human | HL | apoptosis | 33,961,796 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CD276 | 80381 | protein coding | HCT116,RKO | -- | Colorectal cancer | Prevent | CCK-8 assay//Colony formation assay//Flow cytometry//SA--gal activity assay//Western blot | Western blot analysis of p21 and p53 in sh-NC cells or shB7-H3 CRC cells treated with DOX. SA-¦Â-Gal activity of sh-NC cells or shB7-H3 CRC cells treated with DOX was examined. Cell viability in sh-NC cells or shB7-H3 CRC cells treated with DOX after 24, 36, 48, and 96 h was examined by CCK-8 assays. The colony formati... | TM4SF1 | Upregulation | RT-qPCR//Western blot | The mRNA expression of TM4SF1 in EV cells or B7-H3 CRC cells treated with DOX. Western blot analysis of TM4SF1 and p21 in sh-NC cells or shB7-H3 CRC cells treated with DOX. Western blot analysis of TM4SF1 and p21 in EV cells or B7-H3 CRC cells treated with DOX. | AKT-TM4SF1-SIRT1 | Upregulation | Western blot | The western blot results showed that B7-H3 knockdown decreased SIRT1 protein expression, while TM4SF1 overexpression reversed the effect of B7-H3 knockdown on SIRT1 expression in low-dose DOX induced senescent HCT116 and RKO cells. Moreover, B7-H3 overexpression increased SIRT1 protein expression, while TM4SF1 knockdow... | Human | HL | delay aging | 33,958,586 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR27B | 407019 | ncRNA | B-MSC | -- | Osteoarthritis | Accelerate | SA--gal activity assay | Western blot analysis, enzyme-linked immunosorbent assay, and¦Â-galactosidase activity assay were conducted with the results showing that knockdown of miR-27b-3p promoted expression of the osteogenic differentiation markers while inhibiting expression of the adipogenic differentiation markers, inflammatory factors, and... | KDM4B | Downregulation | Luciferase reporter assay//CHIP | After that, the interactions between miR-27b-3p, lysine Demethylase 4B (KDM4B), and Distal-Less Homeobox 5 (DLX5) identified using dual-luciferase reporter gene assay and ChIP assay revealed that miR27b-3p inhibited KDM4B and further reduced expression of DLX5. | -- | -- | -- | -- | Human | HL | cellular senescence | 32,856,377 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MTX2 | 10651 | protein coding | Primary Fibroblast | -- | Mandibuloacral dysplasia | Prevent | SA--gal activity assay | Senescence was examined in cells by a senescence associated ¦Â-galactosidase assay following the manufacturer¡¯s protocol (Cell Signaling #9860). | MTX1 | Upregulation | Western blot | Immunoblot analysis of MTX2 and other outer and inner mitochondrial membrane proteins of whole-cell extracts from healthy control (WT) and patients¡¯ (MADM2, MADM3)fibroblasts. Actin or REVERT total proteins were used as loading controls. n = 3 independent experiments for MTX2, TOMM22, SAMM50, CHCHD3 and n = 2 independ... | -- | -- | -- | -- | Human | HL | apoptosis | 32,917,887 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR29A | 407021 | ncRNA | HMSC | -- | Aging | Prevent | SA--gal activity assay//Western blot | Senescence-associated-¦Â-galactosidase (SA-¦Â-gal) staining. Compared with the siGFP-transfected group, siDGCR8-transfected hMSCs showed increased numbers of The percentage of SA-¦Â-gal-positive cells was significantly higher in siDGCR8-transfected hMSCs. Western blot showing the protein levels of tumour suppressors an... | DNMT3A | Downregulation | Luciferase reporter assay//RT-qPCR//Western blot | 293T cells were co-transfected with luciferase reporters carrying either the wild-type DNMT3A 3¡ä UTR (Dnmt3a) or the mutagenised DNMT3A 3¡ä UTR (mDnmt3a), as well as 50 nM negative control mimic (miR-Control) or miR-29a-3p or/and miR-30c-5p mimics. The mRNA levels of DNMTs were measured by quantitative real-time PCR. ... | -- | -- | -- | -- | Human | HL | cellular senescence | 32,961,441 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR30C1 | 407031 | ncRNA | HMSC | -- | Aging | Prevent | SA--gal activity assay//Western blot | Senescence-associated-¦Â-galactosidase (SA-¦Â-gal) staining. Compared with the siGFP-transfected group, siDGCR8-transfected hMSCs showed increased numbers of The percentage of SA-¦Â-gal-positive cells was significantly higher in siDGCR8-transfected hMSCs. Western blot showing the protein levels of tumour suppressors an... | DNMT3A | Downregulation | Luciferase reporter assay//RT-qPCR//Western blot | 293T cells were co-transfected with luciferase reporters carrying either the wild-type DNMT3A 3¡ä UTR (Dnmt3a) or the mutagenised DNMT3A 3¡ä UTR (mDnmt3a), as well as 50 nM negative control mimic (miR-Control) or miR-29a-3p or/and miR-30c-5p mimics. The mRNA levels of DNMTs were measured by quantitative real-time PCR. ... | -- | -- | -- | -- | Human | HL | cellular senescence | 32,961,441 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PIK3R3 | 8503 | protein coding | LoVo,SW48 | -- | Colorectal cancer | Prevent | CCK-8 assay//Flow cytometry//SA--gal activity assay//Western blot | WB of PIK3R3 and p21 both in LoVo and SW48 cells transfected with siNC, siPIK3R3#1, and siPIK3R3#2. CCK8 assays of LoVo and SW48 cells transfected with PIK3R3-specific siRNA. Cell cycle distribution of LoVo and SW48 cells transfected with siNC, siPIK3R3#1, and siPIK3R3#2 was measured byflow cytometry. SA-¦Â-gal stainin... | P53 | Binding | IP | Immunoprecipitation assays were performed for LoVo cells with antiPIK3R3 or anti-p53 antibodies. | p53-p21 | Downregulation | CHIP//Western blot | ChIP assays of p53 binding to the CDKN1A promoter region in LoVo transfected with PIK3R3-expressing plasmid. WB of PIK3R3, p53, and p21 in LoVo and SW48 cells transfected with PIK3R3 plasmid or/and His-p53 plamid. | Human | L | cellular senescence | 32,973,127 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
POLR3A | 11128 | protein coding | fibroblast | -- | Wiedemann-Rautenstrauch syndrome (WRS) | Prevent | Immunostaining//SA--gal activity assay//Telomere length assay//Western blot | Beta-galactosidase staining (pH 6) was evident at PD 45 in controls, at PD 27 in HGPS, and at PD 36 in WRS fibroblasts (A). Nuclear morphology analyzed by Lamin A immunostaining is shown for HGPS cells (C), control cells (D), and WRS (E) cells. Relative telomere length is shown in (G). | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | cellular senescence | 32,976,914 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CDKN2B-AS1 | 100048912 | ncRNA | HEK293T,HTM | -- | POAG | Prevent | PCR//SA--gal activity assay | The human cellular senescence and extracellular matrix and adhesion molecules RT2 Profiler PCR arrays showed differential gene expression profile in TM cells after 10 nM CDKN2B-AS1 siRNA and control siRNA treatment for 72 h. Senescence-related¦Â-galactosidase staining of TM cells after 10 nM CDKN2B-AS1 siRNA and contro... | CDKN2B | Downregulation | immunocytochemistry//RT-PCR | A marked increase in CDKN2B expression was also observed in TM cells after 10 nM CDKN2B-AS1 siRNA treatment as assessed by immunocytochemistry and RT-PCR. | -- | -- | -- | -- | Human | HL | cellular senescence | 32,825,664 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FOXO4 | 4303 | protein coding | UC-MSC | -- | Aging | Accelerate | CCK-8 assay//SA--gal activity assay | Senescence of hUC-MSCs detected by ¦Â-galactosidase staining. Cell viability assayed by CCK-8. | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | apoptosis | 32,820,304 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LMNA | 4000 | protein coding | HSF,MEF | -- | HGPS | Prevent | SA--gal activity assay//Western blot | Representative images of SA-¦ÂGal staining in HSFs (P17) treated with the indicated siRNAs. Western blot analysis of METTL14, p21, and p16 levels in MEFs (P3) treated with the indicated siRNAs. | METTL3/14 | Binding | Co-IP//Western blot | Co-IP and Western blot analysis of the endogenous interaction between Lamin A and METTL14 and Lamin A and METTL3 in MEFs. | -- | -- | -- | -- | Human | L | delay aging | 32,813,328 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR483 | 619552 | ncRNA | ADSC | -- | Aging | Accelerate | SA--gal activity assay | SA-¦Â-gal staining of hADSCs (P14) transfected with 483-3p-M and corresponding control. | IGF1 | Downregulation | RT-qPCR//ELISA | Efficiency of IGF1 inhibition was assayed by RT-qPCR and ELISA. | -- | -- | -- | -- | Human | HL | cellular senescence | 32,805,717 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CLOCK | 9575 | protein coding | HMSC | -- | Aging | Prevent | Clonal expansion assay//RT-qPCR//SA--gal activity assay | Increased SA-¦Â-gal activity, decreased proliferative potential, and decreased percentage of S-phase cells were detected in CLOCK¨C/¨C hMSCs. CLOCK deficiency resulted in the enhancement of DNA damage response and SASP. we observed downregulated transcription levels of LMNB1 and TMPO and upregulated mRNA expression of ... | Lamin B1,Emerin,KAP1 | Binding | Co-IP | Co-immunoprecipitation (Co-IP) assays verified these new interactions between CLOCK and nuclear lamina/heterochromatin-associated proteins in HEK293T cells and hMSCs. | -- | -- | -- | -- | Human | HL | cellular senescence | 32,737,416 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT1 | 23411 | protein coding | NP | -- | IVDD | Prevent | JC-1 probe staining//ROS staining//SA--gal activity assay//Western blot | The degree of senescence of the NP cells subjected to 0% or 20% (high-magnitude) compressive deformation was analyzed using SA-¦Â-Gal staining (200¡Á). The SIRT1, PGC1¦Á and senescence-related protein (AMPK, P53, P21 and P16) levels were analyzed by Western blotting. After high-compression or high-compression plus Ad-S... | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | cellular senescence | 32,687,063 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR185 | 406961 | ncRNA | HTC75,HFF,MRC5 | -- | Aging | Accelerate | Immunofluorescence//SA--gal activity assay//TRF assay//qRT-PCR | Immunofluorescence and fluorescence in situ hybridization (IF-FISH) were performed in POT1 knockdown, miR-185 overexpression and POT1 rescue HTC75 cells with the indicated¦Ã-H2AX antibody and the TTAGGG telomere probe. Telomere restriction fragment (TRF) analysis showed the telomere length of HTC75 cells stably infecte... | POT1 | Upregulation | Dual-luciferase reporter assay//qRT-PCR//Western blot | By using dual luciferase reporter assay, we compared the effects of miR-185 overexpression on wild-type POT1 (wPOT13¡¯-UTR) or mutant POT1 (mPOT1-3¡¯-UTR) luciferase activity. We stably transfected miR-185 into HTC75 cells and observed a decrease in POT1 mRNA levels. Consistent with the change in mRNA levels, POT1 prot... | ATR | Downregulation | Western blot | The total ATR protein level reduced upon miR-185 overexpression. | Human | L | telomere attrition | 32,687,062 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
ERG | 2078 | protein coding | LNCaP | -- | Aging | Prevent | SA--gal activity assay | Analysis of cellular senescence by senescence-associated (SA)-b-galactosidase (Gal) activity measurement in LNCaP cells after treatment with 0.5 mM daunorubicin or DMSO as control. | p53 | Upregulation | Western blot//Immunofluorescence microscopy | Protein levels of p53 and ERG in control vector and DN-ERG transfected normal human prostatic epithelial cells (hPREC) and LNCaP cells were analyzed by immunoblotting. ERG and p53 expression were evaluated by immunofluorescence microscopy in LNCaP cells transfected with control vector or DN-ERG for 48 h. | -- | -- | -- | -- | Human | HL | apoptosis | 32,674,955 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIB1 | 57534 | protein coding | HCT116,HEK293T | -- | Aging | Accelerate | SA--gal activity assay | Cellular senescence was detected by senescence-associated ¦Â-galactosidase (SA-¦Â-Gal) assay. | WRN | Binding | Co-IP | The protein was extracted for co-immunoprecipitation (co-IP) to detect the interaction between WRN and MIB1. | -- | -- | -- | -- | Human | L | cellular senescence | 32,652,764 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR34A | 407040 | ncRNA | HADMSC | -- | Aging | Accelerate | RT-PCR//SA--gal activity assay//Western blot | The activity of senescence associated¦Â¨C galactosidase (SA-¦Âgal) was assessed by histochemical staining. Moreover, the senescence associated molecular alterations including that of pro-senescence (P53, P21 and P16) and anti-senescence (SIRT1, HTERT and CD44) genes were examined by quantitative RT-PCR and western blot... | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | delay aging | 32,634,429 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IQGAP1 | 8826 | protein coding | VMSC | -- | Aging | Prevent | SA--gal activity assay | Indeed, we observed an increased number of cells with elevated activity of senescence-associated ¦Â-galactosidase (SA-¦Â-gal)¨C a most commonly used senescence marker. | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | altered intercellular communication | 32,592,713 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
NSD2 | 7468 | protein coding | IMR-90 | -- | Aging | Prevent | Flow cytometry//SA--gal activity assay | Cell cycle analysis by propidium iodide staining revealed that the population of cells in G2/M phase was slightly increased on day 6 in NSD2-KD cells. Furthermore, NSD2-depleted cells exhibited SA-¦Â-Gal staining starting on day 3 after siRNA transfection. | -- | -- | -- | -- | RB | -- | Knockdown | Knockdown of RB completely abolished the reduced expression of RB-associated genes such as MCM3, LMNB1, and EZH2 in NSD2-KD cells. | Human | HL | delay aging | 32,573,059 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RTEL1 | 51750 | protein coding | fibroblast | -- | HHS | Prevent | Southern blot | Southern blot and in-gel hybridization analyses were done as described (23) except for the telomeric oligonucleotide probe, which was (AACCCT)3. | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | cellular senescence | 32,542,379 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SIRT7 | 51547 | protein coding | HMSC | -- | Aging | Prevent | Clonal expansion assay//RT-qPCR//SA--gal activity assay//Western blot | We also observed increased percentages of senescence-associated ¦Â-galactosidase (SA-¦Âgal)-positive cells, compromised clonal expansion ability, decreased ratios of Ki67-positive cells and reduced percentages of S-phase cells in SIRT7?/? relative to SIRT7+/+ hMSCs. Consistent with the accelerated senescence phenotypes... | LINE1 | Binding | ChIP-qPCR | Using ChIP-qPCR assay, we detected that SIRT7 bound specific LINE1 promoter regions in SIRT7+/+ but not in SIRT7?/? hMSCs. | cGAS-STING | Downregulation | Western blot | Activation of the cGAS-STING pathway was evident in SIRT7deficient hMSCs, as detected by increased levels of phosphorylated forms of NF-¦ÊB P65, TANK-binding kinase 1 (TBK1) and IFN regulatory factor 3 (IRF3). | Human | L | cellular senescence | 32,504,224 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
ZKSCAN3 | 80317 | protein coding | HMSC | Muscles of nude mice | Aging | Prevent | Clonal expansion assay//Ki67 staining//SA--gal activity assay//Western blot//qPCR | SA-¦Â-gal staining of ZKSCAN3+/+ and ZKSCAN3-/-hMSCs (P10). Clonal expansion ability analysis of ZKSCAN3+/+ and ZKSCAN3-/- hMSCs (P10). Telomere length analysis of ZKSCAN3+/+ and ZKSCAN3-/- hMSCs (P10) by qPCR. Western blot analysis of P16, P21 in ZKSCAN3+/+ and ZKSCAN3-/- hMSCs (P10). Immunostaining of Ki67 in ZKSCAN3... | Lamin B1,LBR,KAP1,HP1¦Á | Binding | Co-IP//Western blot | Co-IP analysis showing that exogenous ZKSCAN3 interacts with Lamin B1, LBR, KAP1 and HP1? proteins in HEK293T cells. Western blot analysis of the expression levels of Lamin B1, LBR, KAP1 and HP1? proteins in ZKSCAN3+/+ and ZKSCAN3-/- hMSCs (P10). | -- | -- | -- | -- | Human | HL | abnormal gene expression | 32,427,330 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
MFN2 | 9927 | protein coding | Chondrocyte | -- | Osteoarthritis | Accelerate | Flow cytometry//SA--gal activity assay | Representative microscopy images of senescence-associated b-galactosidase activity. Flow cytometry analysis of mitochondrial ROS level of NC and siMfn2#3 chondrocytes. | PARKIN | Binding | Western blot//Co-IP | The protein expression of PARKIN, MFN2 in NC siRNA, PARKIN siRNA#1, #2, #3-treated chondrocytes. Chondrocytes were immunoprecipitated with anti-MFN2 or control IgG, the immunoprecipitated complex was detected by Western blotting with anti-PARKIN. | -- | -- | -- | -- | Human | L | mitochondrial dysfunction | 32,416,221 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FBP1 | 2203 | protein coding | HSC | -- | Aging | Accelerate | IHC staining//SA--gal activity assay | We detected significant numbers of SA-¦Â-Gal+ cells in DEN/Cre livers through senescence-associated¦Â-galactosidase (SA-¦Â-Gal) staining. Representative SA-¦Â-Gal and CD140B IHC staining of cryosections from mouse liver sections at 36 weeks. Representative p21 and FOXO4 IHC staining of mouse liver sections at 36 weeks.... | HMGB1 | Upregulation | IF//Immunoblotting | We therefore treated DEN/GFP or DEN/Cre animals with inflachromene (ICM), a small molecule shown to block HMGB1 release45. ICM treatment greatly reduced not only surface tumours, but also microscopic lesions in DEN/Cre mice. ICM did not affect hepatic steatosis, based on comparable TG levels. As expected, cytosolic HMG... | -- | -- | -- | -- | Human | HL | cellular senescence | 32,367,049 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
MIR21 | 406991 | ncRNA | CD4+T,HEK293T | -- | Aging | Prevent | Western blot//miRNA qRT-PCR//qRT-PCR | In the CD4+ T cells of D-gal treated mice, the level of miR-21was significantly decreased in the hPMSC-Exo miR-21 inhibitor treatment group compared with hPMSC-Exo group. Furthermore, the miRNA level of PTEN was markedly increased, while the mRNA levels of HO-1 and NQO1 were significantly decreased after hPMSC-Exo miR-... | PTEN | Downregulation | qRT-PCR | The exosomes treated with different plasmids were co-cultured with CD4+?T cells, and the expression of miR-21 and PTEN was detected. The expression of miR-21 was markedly improved in CD4+?T cells after co-cultured with hPMSC-Exo compared PBS treatment group. Conversely, hPMSC-Exo treatment greatly decreased the express... | PTEN/PI3K-Nrf2 | Activation | Western blot | The expression of PTEN significantly decreased in activated CD4+ T cells after cultured for 72 h, while hPMSC-Exo intervention further decreased the expression of PTEN in activated CD4+ T cells. Furthermore, the phosphorylation of PI3K and Akt were significantly increased in activated CD4+ T cells, and the hPMSC-Exo in... | Human | HL | cellular senescence | 34,887,868 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 |
MIF | 4282 | protein coding | Primary Human NP Cells | Nucleus pulposus | Intervertebral disc degeneration | Prevent | Flow cytometry//SA--gal activity assay//Western blot | The SA-¦Â-Gal staining result indicated that MIF-KO did not affect the senescence rate of the NP cells, but HC loading significantly aggravated the senescence of NP cells. However, MIF-KO further exacerbated the HC loading-induced senescence of NP cells. Flow cytometry was then used to analyze the content of intracellu... | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | mitochondrial dysfunction | 34,306,312 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
UNC5B | 219699 | protein coding | HUVEC | -- | Aging | Accelerate | CCK-8 assay//EdU assay//SA--gal activity assay//qRT-PCR | The proportion of senescent cells was lower among UNC5B-silenced cells than among the control. The mRNA expression of the SASP genes, i.e., IL-1¦Á, IL-1¦Â, IL-8, MCP-1, and ICAM-1, was significantly attenuated by inhibition of UNC5B. Further, the proliferation of control and UNC5B-silenced cells was assessed. As a resu... | -- | -- | -- | -- | P53 | Activation | Western blot//EdU assay//CCK-8 assay | UNC5B-silencing cells showed downregulated protein expression levels of P53 and P21. For further clarification on the relationship between the P53 pathway and senescence induced by UNC5B, this work used PFT¦Á, a P53-specific inhibitor. The presence of PFT¦Á inhibited the upregulation of P53 induced by UNC5B overexpress... | Human | L | cellular senescence | 34,239,689 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
CARTPT | 9607 | protein coding | Primary cortical neurons | Cortex | AD | Prevent | Western blot//qRT-PCR | The western blotting results indicated that p16, TNF¦Á and IL-1¦Â protein expression levels were significantly increased in A¦Â1¨C42-treated primary cortical neurons, but were significantly decreased following pretreatment with CART. Furthermore, RT-qPCR results demonstrated that p16, p53, IL-6 and IL-1¦Â mRNA expressi... | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | cellular senescence | 33,610,183 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
SIRT3 | 23410 | protein coding | NP Cells | Nucleus pulposus | Intervertebral disc degeneration | Prevent | SA--gal activity assay//Western blot | The proportion of SA©\¦Â©\Gal©\positive cells and p16INK4¦Á expression in the LV©\shSIRT3 + H2O2 group was significantly higher than those in the LV©\Ctrl and LV©\Ctrl + H2O2 groups, whereas overexpression of SIRT3 distinctly decreased the percentage of SA©\¦Â©\Gal©\positive cells and p16INK4¦Á expression. In addition,... | -- | -- | -- | -- | AMPK-PGC©\1¦Á | Activation | ROS Assay//Immunofluorescence//Western blot//SA-¦Â-gal activity assay//qRT-PCR | Furthermore, activation of AMPK in NPC noticeably reduced high the iNOS expression and ROS production caused by downregulation of SIRT3; conversely, the inhibition of AMPK in NPC counteracted the decline in iNOS expression and ROS production after SIRT3 overexpression. Additionally, western blot analysis showed that th... | Human | L | cellular senescence | 33,565,085 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EGR2 | 1959 | protein coding | DS HMFs | -- | Aging | Accelerate | ELISA//Immunofluorescence//qRT-PCR | Using multi©\parameter phenotypic analysis to control for off©\target effects, we identified ¡®EGR2 3¡¯ siRNA as the most potent siRNA transfected individually which significantly increased cell number and significantly reversed cell area, nuclear area and cell elongation. ¡®EGR2 2¡¯, the second most potent siRNA trans... | ARF//p16 | Upregulation | CHIP//Western blot | Cells transfected with the pGL3 ARF 800 or with the complete ARF promoter, pGL3 ARF 3.4, displayed a significant increase in luciferase activity following transfection with the EGR2 expression vector or E2F1 positive control, but not EGR1, EGR3 or EGR4 expression vectors, thus confirming EGR2 as a direct activator of t... | p16-pRB//ARF-p53-p21 | Activation | Immunofluorescence | Using immunofluorescence staining and high©\content analysis, we further examined p16 and p21 on a cellular level and found a significant increase in the proportion of double negative (p16? p21?) ¡®reversed¡¯ cells in DS HMFs following EGR2 knockdown in combination with?p21?siRNA (¡®DS?+?EGR2?+?p21?siRNA) compared to t... | Human | HL | cellular senescence | 33,547,862 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
ITPR2 | 3709 | protein coding | MRC5 | -- | Aging | Accelerate | EdU assay//RNA-seq//SA--gal activity assay//Western blot//qRT-PCR | To further confirm a link between the loss of Itpr2 and decreased levels of senescence, beyond the liver, we explored the replicative potential of Itpr2 KO- and WT-derived MEFs. Late passage Itpr2 KO MEFs showed a decreased level of cellular senescence, as illustrated by a decrease in the level of several cellular sene... | -- | -- | -- | -- | -- | -- | -- | -- | Human | HL | cellular senescence | 33,526,781 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
DKC1 | 1736 | protein coding | CD34+ cells | -- | Dyskeratosis congenita | Prevent | TRAP assay//Western blot | These results showed marked decreases in the telomerase activity of CD34+ cells that had been transduced with iDKC1-, iDKC4-, or iDKC7-LVs, which showed values of 42.8%?¡À?19%, 61.5%?¡À?3.6%, and 43.7%?¡À?15.6%, respectively, of values determined in the control group. Analyses of ¦ÃH2AX foci in the nucleus of cells tra... | -- | -- | -- | -- | -- | -- | -- | -- | Human | L | cellular senescence | 33,514,435 | Gene | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.